Presentient Technologies Ltd is a United Kingdom based Information Technology startup that focuses on predicting clinical trial outcomes in realtime. Founded in 2022, the company aims to revolutionize the drug development process. With the rising cost of drug development, Presentient's goal is to reverse this trend and make innovative medicines more affordable.
The company's slogan "Predicting clinical trial outcomes in realtime" encapsulates its core mission. Presentient stands out by being the first to autonomously analyse blinded data from ongoing clinical trials in realtime. This innovative approach is poised to significantly shorten the duration of clinical trials from years to months, ultimately facilitating the swift introduction of new medicines to the market.
Presentient Technologies Ltd secured its Pre-Seed Round investment on 03 March 2023. Notably, the investors in this round were Episode 1 Ventures and QVentures. This financial backing is indicative of the confidence and potential seen in the startup's vision and technological capabilities. With the support of these investors, Presentient is well-positioned to drive impactful change in the pharmaceutical industry and improve patient access to affordable medicines.
